TRAW Traws Pharma Inc.

Price (delayed)

$0.5036

Market cap

$7.74M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$1.76

Enterprise value

$2.72M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 0

Traws Pharma is a clinical-stage biopharmaceutical company developing novel therapies to target critical threats to human health from respiratory viral diseases. The company is advancing investigational oral small molecule antiviral ...

Highlights
The equity has surged by 132% since the previous quarter but it has dropped by 80% year-on-year
The quick ratio has surged by 117% since the previous quarter but it has dropped by 71% year-on-year
The company's revenue has shrunk by 100% QoQ and by 100% YoY
The gross profit has dropped by 100% since the previous quarter and by 100% year-on-year

Key stats

What are the main financial stats of TRAW

TRAW stock price

How has the Traws Pharma stock price performed over time
Intraday
0.72%
1 week
-5.55%
1 month
-4.98%
1 year
-73.21%
YTD
-55.43%
QTD
-40.28%

Financial performance

How have Traws Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$21.54M
Net income
-$16.74M
Gross margin
N/A
Net margin
N/A
The company's revenue has shrunk by 100% QoQ and by 100% YoY
The gross profit has dropped by 100% since the previous quarter and by 100% year-on-year
Traws Pharma's net income has plunged by 99% YoY and by 13% from the previous quarter
The company's operating income fell by 10% QoQ and by 6% YoY

Price vs fundamentals

How does TRAW's price correlate with its fundamentals

Growth

What is Traws Pharma's growth rate over time

Valuation

What is Traws Pharma stock price valuation
P/E
N/A
P/B
4.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has grown by 37% YoY but it has contracted by 2.9% from the previous quarter
The equity has surged by 132% since the previous quarter but it has dropped by 80% year-on-year
The company's revenue has shrunk by 100% QoQ and by 100% YoY

Efficiency

How efficient is Traws Pharma business performance
TRAW's return on assets is down by 24% since the previous quarter

Dividends

What is TRAW's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for TRAW.

Financial health

How did Traws Pharma financials performed over time
TRAW's total assets is 17% greater than its total liabilities
The quick ratio has surged by 117% since the previous quarter but it has dropped by 71% year-on-year
The current ratio has soared by 116% from the previous quarter but it has plunged by 56% YoY
The debt is 100% less than the equity
The equity has surged by 132% since the previous quarter but it has dropped by 80% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.